{'fraction_non_alphanumeric': 0.026019690576652602, 'fraction_numerical': 0.01828410689170183, 'mean_word_length': 5.352678571428571, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Using Innovative Technologies to Set New Safety Standards for the Infusion of Intravenous Medications

Intravenous (IV) administration errors present a particularly challenging problem to hospital pharmacists. Current control systems intercept only 2% of drug administration errors causing preventable adverse drug events (PADEs).4 Estimated costs per preventable ADE are $4685 (1993 dollars). Of the most serious, life-threatening errors, 60% are associated with IV therapy. Conventional, general-purpose infusion devices cannot limit doses or easily be customized for specific patient populations. Clarian Health Partners, a 1400-bed health care system, consolidated infusion devices at three hospitals by implementing the MEDLEY Medication Safety System with Guardrails Safety Software. This new technology offers an innovative IV medication safety platform that functions at the point of care. Clarian became the first U.S. health care system to use this system on a hospital-wide basis. Development of a customized data set based on Clarian's best-practice guidelines was completed in 60 days, and installation at the 775-bed Methodist Hospital was completed in 3 hours. A potentially serious error was averted on the first day of system use. Initial data indicate that use of the IV medication safety system at Clarian's three hospitals will result in 4,000 events of reprogramming annually due to Guardrails alerts.